A multicenter, double-blind randomized placebo-controlled comparison of the effects on sexual functioning of extended-release bupropion hydrochloride (300-450mg) and escitalopram (10-20mg) in outpatients with moderate to severe major depression over an eight-week treatment period
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2005
At a glance
- Drugs Bupropion; Escitalopram
- Indications Depression; Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2005 New trial record.